NBY icon

NovaBay Pharmaceuticals
NBY

Overview Fund Activity

18 hedge funds and large institutions have $2.6M invested in NovaBay Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$883K
2
EWA
2
Exencial Wealth Advisors
Oklahoma
$71K
3
OL
3
Orbitronix LP
California
$31K
4
BFO
4
Boston Family Office
Massachusetts
$22K
5
Citadel Advisors
5
Citadel Advisors
Florida
$20K

Top Sellers

1
SC
1
Sophrosyne Capital
New York
$0
2
Millennium Management
2
Millennium Management
New York
$0
3
SIM
3
Spark Investment Management
New York
$0
4
VKH
4
Virtu KCG Holdings
New York
$0
5
OC
5
Oppenheimer & Co
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SC
26
Sophrosyne Capital
New York
– -$2.77M -53 Closed
Millennium Management
27
Millennium Management
New York
– -$862K -16 Closed
VKH
28
Virtu KCG Holdings
New York
– -$36K -1 Closed
SIM
29
Spark Investment Management
New York
– -$47K -1 Closed
Bank of America
30
Bank of America
North Carolina
– -$1K – –
OC
31
Oppenheimer & Co
New York
– -$26K – –
1
2